Lambipol

Lamotrigine, the active ingredient in Lambipol, is an anticonvulsant presented as an oral tablet for oral use. It is used to control seizures in patients with epilepsy and to stabilize mood in individuals with bipolar disorder, working by reducing abnormal neuronal firing and decreasing excitatory neurotransmitter release.

GNH USA supplies Lambipol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Lamotrigine is employed in the management of seizure disorders and mood stabilization, targeting neuronal excitability.

- Epilepsy (partial seizures): reduces the frequency of focal onset seizures. - Epilepsy (generalized tonic‑clonic seizures): helps prevent convulsive episodes. - Bipolar disorder: maintains mood stability and lowers the risk of relapse.

Lamotrigine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset, sometimes with vomiting. - Rash: skin redness or itching, usually mild. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: abnormal blood counts such as agranulocytosis. - Hepatic failure: impaired liver function. - Aseptic meningitis: inflammation of the meninges without infection. - Severe hypersensitivity reactions: including anaphylaxis.

When prescribing lamotrigine, several safety considerations are recommended.

- Dose titration: increase gradually to minimize rash risk. - Renal/hepatic impairment: adjust dose as needed based on organ function. - Pregnancy: category B, discuss benefits and risks with a healthcare provider. - Concomitant use with valproate: monitor plasma levels closely due to increased exposure. - Avoid abrupt discontinuation: taper slowly to prevent seizure recurrence. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: raises lamotrigine levels, increasing toxicity risk. - Carbamazepine: lowers lamotrigine levels, potentially reducing efficacy. - Phenobarbital: decreases lamotrigine concentrations, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce lamotrigine levels; dose may need adjustment. - Phenytoin: decreases lamotrigine concentrations, monitor seizure control. - Rifampin: induces metabolism, lowering lamotrigine exposure.